| Code | CSB-RA765090MB1HU |
| Size | US$9799 |
| Order now | |
| Have Questions? | Leave a Message or Start an on-line Chat |
This recombinant monoclonal antibody is a research-grade biosimilar to DISC-0974, designed for research targeting hemojuvelin (HJV), a critical regulator of iron homeostasis. HJV functions as a co-receptor for bone morphogenetic proteins (BMPs) and plays an essential role in hepcidin regulation through the BMP-SMAD signaling pathway. By modulating hepcidin expression, HJV controls systemic iron levels and erythropoiesis. Dysregulation of HJV is implicated in various iron metabolism disorders, including juvenile hemochromatosis, a severe form of hereditary iron overload caused by loss-of-function mutations in the HJV gene. Additionally, HJV has emerged as a therapeutic target for conditions involving hepcidin deficiency or excess, such as anemia of chronic disease and beta-thalassemia.
DISC-0974 represents a research tool for investigating HJV biology and its role in iron regulatory pathways. This biosimilar antibody enables researchers to explore HJV-mediated mechanisms in iron homeostasis, evaluate potential therapeutic interventions for iron-related disorders, and study the interplay between HJV, hepcidin, and erythropoiesis in various experimental models.
There are currently no reviews for this product.